DEKRA, a leading international expert organization, will be holding its Commercial Vehicle Outlook Conference for the second time in Berlin on November 7 and November 8, 2017. During this two-day period, experts in the areas of vehicle and system production, politics and the transport sector will discuss the most important topics in the years to come. The conference will also focus on automation and connectivity.
“The Commercial Vehicle Outlook Conference is a top-class central platform for all participants to exchange ideas about commercial vehicles and their safety and sustainability,” said Clemens Klinke, a member of DEKRA’s Management Board. “We can look forward to exciting contributions from manufacturers and suppliers as well as professionals in the transport sector, politics and science.”
The President of the German Association of the Automotive Industry (VDA), Matthias Wissmann, and other high-ranking company and authority representatives have also confirmed their attendance The individual sessions will deal with various topics, including digitalization, active safety, automated driving, electric motors, CO2 emissions and the latest developments in the field of telematics. The European Commercial Vehicle Safety Award – jointly presented by DEKRA, DVR and EVU – and ETM Verlag’s German Telematics Prize will also be awarded at the conference.
You can register online and find the full program and all other information at: www.zukunftskongress-nutzfahrzeuge.de.
“DEKRA has been promoting safety for more than 90 years now. The safety of commercial vehicles was already key when the German Motor Vehicle Inspection Association was founded in 1925 in Berlin,” said DEKRA Management Board Member Klinke. DEKRA is now one of the world’s leading expert organizations operating in over 50 countries on all five continents. And even though our safety efforts cover a wider range of areas now, the safety of commercial vehicles – in the interest of DEKRA e.V.’s 23,000 members, which, for the most part, are from the transport sector – will remain one of our key concerns in the future.”